Retention quantity for Europe Submission study [Regulatives / Guidelines]

posted by achintparikh – India, 2012-11-03 13:44 (4983 d 09:57 ago) – Posting: # 9498
Views: 13,036

Dear

How much units of Investigational Product need to be kept as retention for pharmacodynamic study conducted for Europe submission?

Is there any relation between number of units used for the study and number of units retained as retention sample?

Please give your view and if possible, give reference of relevant guideline / Directive.

Thanks
Pradeep Labana

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
381 visitors (0 registered, 381 guests [including 19 identified bots]).
Forum time: 00:42 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5